Table 2.
Baseline Characteristics of the Study Group
| All | WT | B.1.1.7 | |
|---|---|---|---|
| Total No. of patients | 1192 | 485 | 251 |
| Background | |||
| Age, y, median (IQR) | 61 (52–70) | 63 (55–72) | 61 (51–70) |
| Sex, male/total (%) | 804/1192 (67.4) | 345/485 (71.1) | 166/251 (66.1) |
| Ethnicity, nonwhite/total (%) | 86/302 (28.5) | 50/167 (29.9) | 7/21 (33.3) |
| BMI, median (IQR) | 30.8 (26.7–36.0) | 30.1 (26.6–35.4) | 31.8 (27.4–37.4) |
| Preexisting comorbidities, No./total (%) | |||
| Immunocompromised | 54/1190 (4.5) | 28/485 (5.8) | 14/251 (5.6) |
| Diabetes | 361/1190 (30.3) | 163/485 (33.6) | 74/251 (29.5) |
| Respiratory disease | 274/1190 (23.0) | 129/485 (26.6) | 45/251 (17.9) |
| Cardiovascular disease | 98/1162 (8.4) | 44/477 (9.2) | 13/245 (5.3) |
| Severity | |||
| APACHE II score, median (IQR) | 12 (8–19) | 14 (9–20) | 12 (7.5–18) |
| Invasive ventilation, No./total (%) | 415/1192 (34.8) | 192/485 (39.6) | 96/251 (38.2) |
Abbreviations: BMI. Body mass index; IQR, interquartile range; WT, wild type.